The parts of the brain that are needed to remember words, and how these are affected by a common form of epilepsy, have been identified by a team of neurologists and neurosurgeons at UCL.
Anti-amyloid drug shows signs of preventing Alzheimer’s dementia
An experimental drug appears to reduce the risk of Alzheimer’s-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a study led by the Knight Family Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU), which is based at Washington University School of Medicine in St. Louis.
Medical researchers lose federal grants to study vaccine hesitancy and Alzheimer’s
Researchers at the University of Colorado’s Anschutz Medical Campus have lost two scientific grants since President Donald Trump returned to office, but worry they’ll lose both money and their future colleagues if the federal grant funding upheaval continues.
Removing a protein ‘signal jammer’ improves tumor response to immunotherapy
Targeted inhibition of a “signal jammer” protein may improve how tumors respond to immunotherapy. Published today in Nature, a new study demonstrates how some cancer cells use the protein voltage-dependent anion channel 2 (VDAC2) as a signal jammer to prevent the body’s anticancer systems from communicating with the immune system.
Thermal imaging could be a simple, highly accurate way to track vital signs
Biomedical engineers at Georgia Tech have developed a system for collecting and processing thermal images that allows for reliable, detailed measurement of vital signs such as respiration and heart rate or body temperature.
Breakthrough gene therapy alleviates Dravet syndrome symptoms in mice without side effects
In a groundbreaking advancement for families grappling with the challenges of Dravet syndrome, a rare and life-altering form of epilepsy, scientists have developed a new gene replacement therapy in mice that could lead to more effective treatments in humans.
Study finds persistent delirium in skilled nursing facilities dropped between 2014 and 2019
A new study that looked at possible improvements in post-acute care quality and outcomes following the 2014 Improving Medicare Post-Acute Care Transformation (IMPACT) Act found that delirium prevalence at admission to skilled nursing facilities (SNF) decreased over five years, from 4.3% in 2014 to 2.5% in 2019.
Oklahoma now reporting measles cases related to Texas/New Mexico outbreak
As the number of cases in the Texas measles outbreak continues to climb, Oklahoma is now reporting four cases, according to the Oklahoma State Department of Health.
Navigating anxiety: How emergency alerts impact mental health and coping strategies
When there’s a disaster, it’s helpful to know what’s going on—and know whether you’re truly at risk. But as essential as emergency alert systems are, they can leave many of us feeling anxious—even when the alert may be a false alarm or test.
Case study: Bartonella and Babesia found in brain tissue of child with seizures
In a recent case study, researchers from North Carolina State University found Bartonella henselae, Babesia odocoilei and Babesia divergens-like MO-1 DNA in brain tissue samples from a young child with seizures and suspected Rasmussen’s encephalitis. The findings further support the idea that these pathogens can be a cofactor in complex neurological illnesses.